Industry Verticals »

All Categories

Insights »

About TMR »

Europe and MEA Culture Test for Healthcare-associated Infections Market

Europe and MEA Culture Test for Healthcare-associated Infections Market (Product: Instruments, Reagents and Consumables; Test Type: Escherichia coli infection, Staphylococcus aureus infection, Enterococcus species infection, Pseudomonas aeruginosa infection, Clostridium difficile infection, Enterobacter Species and Others; Target Area: Bloodstream, Urinary Tract, Surgical Site, Gastrointestinal, Respiratory and Others) - Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

Europe and MEA Culture Test for Healthcare-associated Infections Market Outlook 2034

  • Europe and Middle-East & Africa industry was valued at US$ 270.3 Mn in 2023
  • It is projected to advance at a CAGR of 2.9% from 2024 to 2034 and reach more than US$ 371.3 Mn by the end of 2034

Analyst Viewpoint Regarding Europe and MEA Culture Test for Healthcare-associated Infections Market

The increasing incidence of infections acquired in healthcare settings has prompted a growing emphasis on culture tests as essential diagnostic tools. With the growing volume of surgical procedures and hospital admissions across Europe and the MEA region, the risk of healthcare-associated infections also rises, leading to higher morbidity, mortality as well as healthcare costs. This alarming trend has necessitated policymakers to put infection prevention and control strategies into practice at healthcare settings.

Further, heightened awareness among healthcare practitioners regarding the need of infection control measures has fueled the demand for culture tests for healthcare-associated infections (HAIs). Additionally, organizations such as the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) advocate for routine screening and monitoring of infections through circulation of stringent regulatory mandates and guidelines, further driving the demand for effective culture testing methods, contributing toward Europe and MEA culture test for HAIs market expansion.

There have been notable advancements in culture testing techniques over the past decades, contributing to Europe and MEA culture test for Healthcare-associated infections market expansion through enhancing the speed and accuracy of infection identification.

Moreover, these innovations enable expedited clinical decisions and lead to improved patient outcomes by allowing accurate treatment interventions. As healthcare facilities strive to meet quality improvement initiatives and accreditation standards, the adoption of culture tests for HAIs is poised to escalate, bolstering market growth.

Europe and MEA Culture Test for Healthcare-associated Infections Market Outlook

Healthcare-associated infections (HAIs) are infections that patients acquire while receiving medical treatment for the other conditions within healthcare settings such as hospitals, nursing homes, and outpatient clinics. Surgical site infections, bloodstream infections, urinary tract infections, and pneumonia are some of the various forms of HAIs. Several pathogens are responsible for these infections including Staphylococcus aureus, Escherichia coli, and Clostridium difficile, among others.

Patient safety and healthcare quality are gravely threatened by the incidence of HAIs, which raises rates of morbidity and mortality, lengthens hospital stays, and raises healthcare expenses. Culture testing is a critical diagnostic tool for management and prevention of HAIs.

This diagnostic method allows healthcare providers to pinpoint the precise pathogen causing illnesses and also ascertain their susceptibility to antibiotics, allowing for more focused and effective therapy. Additionally, through culture testing, infection trends can be studied accurately, in turn, aiding infection control practices, and devising public health strategies.

Attribute Detail
Europe and MEA Culture Test for Healthcare-associated Infections Market Drivers
  • Increasing Prevalence of Healthcare-associated Infections
  • Rising Awareness and Adoption of Infection Control Measures

Increasing Prevalence of Healthcare-associated Infections Boosting Europe and MEA Culture Test for Healthcare-associated Infections Market

The increasing prevalence of HAIs is significantly influencing the growth of the Europe and the Middle East and Africa culture test for healthcare-associated infections market over the forecast period. HAIs, such as hospital-acquired pneumonia (HAP), surgical site infections (SSIs), and bloodstream infections (BSIs), pose significant threat for healthcare facilities, as they lead to increased morbidity, mortality, and healthcare costs.

For instance, according to data published by European Centre for Disease Prevention and Control (ECDC) in May 2024, 4.3 million patients in hospitals in the EU/EEA acquire at least one healthcare-associated infection during their stay in the hospital each year.

With the rise in aging population and the ongoing surge in the prevalence of chronic diseases, more patients are seeking medical care, leading to an increased rate of hospital admissions. This rise in patient turnover heightens the risk of HAIs, as more individuals receive invasive procedures and treatments in healthcare settings.

The complexity of care is increased by developments in medical technology and treatment options, including immunosuppressive medicines and operations. Although these advancements have the potential to save lives, they also increase the danger of infection, especially for susceptible patient groups.

Rising Awareness and Adoption of Infection Control Measures Driving Growth of Europe and MEA Culture Test for Healthcare-associated Infections Market

Increasing awareness and adoption of infection control measures is expected to drive the Europe and MEA culture test for healthcare-associated infections market over the forecast period. With the rising awareness among healthcare providers and patients regarding the risks associated with HAIs, they are increasingly adopting infection control measures to prevent and control such infections.

This growing awareness is driving the demand for culture tests, which are a critical component of infection control measures. In order to take swift and targeted actions to prevent the spread of HAIs, healthcare professionals utilize culture tests to identify and track infections. As a result, the market for culture tests for identifying HAIs is expected to experience significant growth, driven by the increasing demand for effective infection control measures.

Governments and health authorities in Europe and the MEA are introducing stringent regulations aimed at reducing HAIs. In order to comply with these regulations, healthcare settings are often required to adopt culture testing as part of infection control protocols, further propelling Europe and MEA culture test for healthcare-associated infections market growth.

Further, collaborations between healthcare organizations, governmental bodies, and international health agencies in Europe and the MEA has fostered the sharing of best practices and resources for infection control. These initiatives promote the adoption of culture testing as a standard practice in infection management.

High Demand for Reagents and Consumables

Europe and MEA culture test for healthcare-associated infections market segmentation based on product includes instruments, and reagents and consumables.

The Reagents and Consumables segment accounts for largest revenue share in the Culture Test for Healthcare-associated Infections Market primarily as these products are used in every culture test, leading to constant replenishment and higher overall demand.

Instruments, on the other hand, are typically purchased less frequently. Additionally, compared to instruments, reagents and consumables demand a smaller initial expenditure. This increases sales volumes by making products more affordable for smaller labs and medical establishments.

Escherichia coli infection Driving Europe and MEA Culture Test for Healthcare-associated Infections Market Statistics

According to Europe and MEA culture test for healthcare-associated infections market industry report, based on test type, the market is classified into Escherichia coli infection, Staphylococcus aureus infection, Enterococcus species infection, Pseudomonas aeruginosa infection, Clostridioides diffcile infection, Enterobacter Species and Others. The Escherichia coli infection segment dominates the market.

It is important to note that E. coli is one of the most frequently isolated pathogens in healthcare-associated infections, particularly in urinary tract infections (UTIs) and gastrointestinal illnesses. Its widespread occurrence leads to a higher demand for testing.

Numerous illnesses, such as gastroenteritis, bloodstream infections, and UTIs, can be brought on by E. coli. The necessity for cultural testing in various healthcare settings is increased by this diversity. Additionally, the rise of antibiotic-resistant strains of E. coli, such as extended-spectrum beta-lactamase (ESBL) producing strains, has heightened the need for accurate culture tests to guide effective treatment options.

Regional Outlook of Europe and MEA Culture Test for Healthcare-associated Infections Industry

Attribute Detail
Leading Region Europe

According to the latest Europe and MEA Culture Test for Healthcare-associated Infections Market analysis, Europe held dominant share in 2023. The market expansion is driven by factors such as aging population and increased volume of surgical procedures. This has heightened the demand for effective diagnostic tools for identification of HAIs, including culture tests.

The market growth is driven by factors such as strict enforcement of infection control rules and policies by the European regulatory agencies that highlight the significance of precise diagnostic testing for the management of HAIs.

Within Europe, Germany emerged as the largest market for culture tests for HAIs industry. This can be attributed to Germany’s highly developed healthcare system with state-of-the-art hospitals, laboratories, and healthcare facilities. This infrastructure enables the implementation of advanced diagnostic technologies, including culture tests for HAIs.

Further, organizations like the Robert Koch Institute, the German federal authority for public health and infectious diseases, enforce Germany's stringent laws and policies for patient safety and infection control. The use of reliable diagnostic instruments, such as culture tests, is required to comply with these regulations.

Analysis of Key Players in Europe and MEA Culture Test for Healthcare-associated Infections Market

As culture test for HAI providers are constantly innovating to improve product capabilities, innovative technologies are being introduced for better efficacy.

Abbott Laboratories, Merck KGA, Becton Dickinson and Company, Steris Plc, Hologic, Inc., bioMerieux SA, F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Hardy Diagnostics, Bio-Rad Laboratories, Inc., Danaher Corporation, and SSI Diagnostica A/S are the prominent culture test for HAIs market players.

Key Developments in Europe and MEA Culture Test for Healthcare-associated Infections Market

  • In July 2024, Midmark Corporation launched its next-generation M11 and M9 steam sterilizers, designed for enhanced durability & ease of use. These sterilizers feature integrated capabilities to improve instrument processing and compliance documentation efficiencies.
  • In July 2023, Merck expanded its facility in Lenexa, Kansas, US to become the largest dry powder cell culture media facility and Center of Excellence in North America. The expansion will add 9,100 sq meters of lab space and production capability to manufacture cell culture media, an essential raw material used in life-saving therapies and biomanufacturing processes. The investment is poised to increase local and global production capacity to meet current demand and ensure a robust supply for future demand surges. Merck has three Centers of Excellence for dry powder cell culture media manufacturing, serving the Americas, Asia Pacific, and Europe, Middle East, and Africa regions.
  • In June 2023, MMM Group and Southwest Clinic jointly established a new CSSD/RUMED facility at the Calw clinic site on Robert-Bosch-Straße 13. This state-of-the-art facility handles the reprocessing of medical products, including Critical C-level items, for four clinics.

Each of these players has been have been profiled in the Europe and MEA Culture Test for Healthcare-associated Infections Market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Europe and MEA Culture Test for Healthcare-associated Infections Market Snapshot

Attribute Detail
Size in 2023 US$ 270.3 Mn
Forecast Value in 2034 More than US$ 371.3 Mn
CAGR 2.9%
Forecast Period 2024-2034
Historical Data Available for 2020-2023
Quantitative Units US$ Mn for Value Thousand Units for Volume
Market Analysis It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis.
Competition Landscape
  • Competition Matrix
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Segmentation
  • Product
    • Instruments
    • Reagents and Consumables
  • Test Type
    • Escherichia coli infection
    • Staphylococcus aureus infection
    • Enterococcus species infection
    • Pseudomonas aeruginosa infection
    • Clostridium diffcile infection
    • Enterobacter Species
    • Others
  • Target Area
    • Bloodstream
    • Urinary Tract
    • Surgical Site
    • Gastrointestinal
    • Respiratory
    • Others
  • Sample Type
    • Blood
    • Urine
    • Stool
    • Tissue
    • Others
  • End-user
    • Hospitals & Clinics
    • Nursing Homes
    • Ambulatory Surgical Centers
    • Others
Regions Covered
  • Europe
  • Middle East and Africa
Countries Covered
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Switzerland
  • Netherlands
  • Rest of Europe
  • Saudi Arabia
  • UAE
  • South Africa
  • Turkey
  • Egypt
  • Israel
  • Rest of MEA
Companies Profiled
  • Abbott Laboratories
  • Merck KGA
  • Becton Dickinson and Company
  • Steris Plc
  • Hologic, Inc.
  • bioMerieux SA
  • F. Hoffmann-La Roche AG
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Hardy Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • SSI Diagnostica A/S
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the Europe and MEA culture test for healthcare-associated infections market in 2023?

Europe and MEA culture test for healthcare-associated infections market was valued at US$ 270.3 Mn in 2023.

How big will the Europe and MEA culture test for healthcare-associated infections business be in 2034?

Europe and MEA culture test for healthcare-associated infections market is projected to reach more than US$ 371.3 Mn by the end of 2034.

What will be the CAGR of the Europe and MEA culture test for healthcare-associated infections industry during the forecast period?

The CAGR is anticipated to be 2.9% from 2024 to 2034.

Who are the prominent Europe and MEA culture test for healthcare-associated infections providers?

Abbott Laboratories, Merck KGA, Becton Dickinson and Company, Steris Plc, Hologic, Inc., bioMerieux SA, F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Hardy Diagnostics, Bio-Rad Laboratories, Inc., Danaher Corporation, and SSI Diagnostica A/S.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Europe and MEA Culture Test for Healthcare-associated Infections Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Segment Definition

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Europe and MEA Culture Test for Healthcare-associated Infections Market Analysis and Forecast, 2020-2034

            4.4.1. Market Revenue Projections (US$ Mn)

            4.4.2. Market Volume/Unit Shipments Projections

    5. Key Insights

        5.1. Key Industry Events

        5.2. Epidemiology of Diseases by Key Countries

        5.3. Pricing Trend by Test Type

        5.4. Insights on Inter-professional Approach to Healthcare-Associated Infections

        5.5. Overview- Healthcare Associated Infections

        5.6. Classification and characterization of HAI according to type

        5.7. Representation of the most common isolated bacteria responsible for HAI

        5.8. PEST Analysis

        5.9. Regulatory Scenario by Key Countries/Regions

        5.10. PORTER's Five Forces Analysis

        5.11. Unmet Needs of the Market

    6. Europe and MEA Culture Test for Healthcare-associated Infections Market Analysis and Forecast, by Product

        6.1. Introduction & Definition

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Product, 2020-2034

            6.3.1. Instruments

            6.3.2. Reagents and Consumables

        6.4. Market Attractiveness Analysis, by Product

    7. Europe and MEA Culture Test for Healthcare-associated Infections Market Analysis and Forecast, by Test Type

        7.1. Introduction & Definition

        7.2. Key Findings/Developments

        7.3. Market Value & Volume Forecast, by Test Type, 2020-2034

            7.3.1. Escherichia coli infection

            7.3.2. Staphylococcus aureus infection

            7.3.3. Enterococcus species infection

            7.3.4. Pseudomonas aeruginosa infection

            7.3.5. Clostridioides difficile infection

            7.3.6. Enterobacter Species

            7.3.7. Others

        7.4. Market Attractiveness Analysis, by Test Type

    8. Europe and MEA Culture Test for Healthcare-associated Infections Market Analysis and Forecast, by Target Area

        8.1. Introduction & Definition

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by Target Area, 2020-2034

            8.3.1. Bloodstream

            8.3.2. Urinary Tract

            8.3.3. Surgical Site

            8.3.4. Gastrointestinal

            8.3.5. Respiratory

            8.3.6. Others

        8.4. Market Attractiveness Analysis, by Target Area

    9. Europe and MEA Culture Test for Healthcare-associated Infections Market Analysis and Forecast, by Sample Type

        9.1. Introduction & Definition

        9.2. Key Findings/Developments

        9.3. Market Value Forecast, by Sample Type, 2020-2034

            9.3.1. Blood

            9.3.2. Urine

            9.3.3. Stool

            9.3.4. Tissue

            9.3.5. Others

        9.4. Market Attractiveness Analysis, by Sample Type

    10. Europe and MEA Culture Test for Healthcare-associated Infections Market Analysis and Forecast, by End-user

        10.1. Introduction & Definition

        10.2. Key Findings/Developments

        10.3. Market Value Forecast, by End-user, 2020-2034

            10.3.1. Hospitals & Clinics

            10.3.2. Nursing Homes

            10.3.3. Ambulatory Surgical Centers

            10.3.4. Others

        10.4. Market Attractiveness Analysis, by End-user

    11. Europe and MEA Culture Test for Healthcare-associated Infections Market Analysis and Forecast, by Region

        11.1. Key Findings

        11.2. Market Value Forecast, by Region, 2020-2034

            11.2.1. Europe

            11.2.2. MEA

        11.3. Market Attractiveness Analysis, by Region

    12. Europe Culture Test for Healthcare-associated Infections Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product, 2020-2034

            12.2.1. Instruments

            12.2.2. Reagents and Consumables

        12.3. Market Value & Volume Forecast, by Test Type, 2020-2034

            12.3.1. Escherichia coli infection

            12.3.2. Staphylococcus aureus infection

            12.3.3. Enterococcus species infection

            12.3.4. Pseudomonas aeruginosa infection

            12.3.5. Clostridioides difficile infection

            12.3.6. Enterobacter Species

            12.3.7. Others

        12.4. Market Value Forecast, by Target Area, 2020-2034

            12.4.1. Bloodstream

            12.4.2. Urinary Tract

            12.4.3. Surgical Site

            12.4.4. Gastrointestinal

            12.4.5. Respiratory

            12.4.6. Others

        12.5. Market Value Forecast, by Sample Type, 2020-2034

            12.5.1. Blood

            12.5.2. Urine

            12.5.3. Stool

            12.5.4. Tissue

            12.5.5. Others

        12.6. Market Value Forecast, by End-user, 2020-2034

            12.6.1. Hospitals & Clinics

            12.6.2. Nursing Homes

            12.6.3. Ambulatory Surgical Centers

            12.6.4. Others

        12.7. Market Value Forecast, by Country/Sub-region, 2020-2034

            12.7.1. Germany

            12.7.2. U.K.

            12.7.3. France

            12.7.4. Italy

            12.7.5. Spain

            12.7.6. Switzerland

            12.7.7. Netherlands

            12.7.8. Rest of Europe

        12.8. Market Attractiveness Analysis

            12.8.1. By Product

            12.8.2. By Test Type

            12.8.3. By Target Area

            12.8.4. By Sample Type

            12.8.5. By End-user

            12.8.6. By Country/Sub-region

        12.9. Germany Culture Test for Healthcare-associated Infections Market Analysis and Forecast

            12.9.1. Introduction

                12.9.1.1. Key Findings

            12.9.2. Market Value Forecast, by Product, 2020-2034

                12.9.2.1. Instruments

                12.9.2.2. Reagents and Consumables

            12.9.3. Market Value & Volume Forecast, by Test Type, 2020-2034

                12.9.3.1. Escherichia coli infection

                12.9.3.2. Staphylococcus aureus infection

                12.9.3.3. Enterococcus species infection

                12.9.3.4. Pseudomonas aeruginosa infection

                12.9.3.5. Clostridioides difficile infection

                12.9.3.6. Enterobacter Species

                12.9.3.7. Others

            12.9.4. Market Value Forecast, by Target Area, 2020-2034

                12.9.4.1. Bloodstream

                12.9.4.2. Urinary Tract

                12.9.4.3. Surgical Site

                12.9.4.4. Gastrointestinal

                12.9.4.5. Respiratory

                12.9.4.6. Others

            12.9.5. Market Value Forecast, by Sample Type, 2020-2034

                12.9.5.1. Blood

                12.9.5.2. Urine

                12.9.5.3. Stool

                12.9.5.4. Tissue

                12.9.5.5. Others

            12.9.6. Market Value Forecast, by End-user, 2020-2034

                12.9.6.1. Hospitals & Clinics

                12.9.6.2. Nursing Homes

                12.9.6.3. Ambulatory Surgical Centers

                12.9.6.4. Others

            12.9.7. Market Attractiveness Analysis

                12.9.7.1. By Product

                12.9.7.2. By Test Type

                12.9.7.3. By Target Area

                12.9.7.4. By Sample Type

                12.9.7.5. By End-user

        12.10. U.K Culture Test for Healthcare-associated Infections Market Analysis and Forecast

            12.10.1. Introduction

                12.10.1.1. Key Findings

            12.10.2. Market Value Forecast, by Product, 2020-2034

                12.10.2.1. Instruments

                12.10.2.2. Reagents and Consumables

            12.10.3. Market Value & Volume Forecast, by Test Type, 2020-2034

                12.10.3.1. Escherichia coli infection

                12.10.3.2. Staphylococcus aureus infection

                12.10.3.3. Enterococcus species infection

                12.10.3.4. Pseudomonas aeruginosa infection

                12.10.3.5. Clostridioides difficile infection

                12.10.3.6. Enterobacter Species

                12.10.3.7. Others

            12.10.4. Market Value Forecast, by Target Area, 2020-2034

                12.10.4.1. Bloodstream

                12.10.4.2. Urinary Tract

                12.10.4.3. Surgical Site

                12.10.4.4. Gastrointestinal

                12.10.4.5. Respiratory

                12.10.4.6. Others

            12.10.5. Market Value Forecast, by Sample Type, 2020-2034

                12.10.5.1. Blood

                12.10.5.2. Urine

                12.10.5.3. Stool

                12.10.5.4. Tissue

                12.10.5.5. Others

            12.10.6. Market Value Forecast, by End-user, 2020-2034

                12.10.6.1. Hospitals & Clinics

                12.10.6.2. Nursing Homes

                12.10.6.3. Ambulatory Surgical Centers

                12.10.6.4. Others

            12.10.7. Market Attractiveness Analysis

                12.10.7.1. By Product

                12.10.7.2. By Test Type

                12.10.7.3. By Target Area

                12.10.7.4. By Sample Type

                12.10.7.5. By End-user

        12.11. France Culture Test for Healthcare-associated Infections Market Analysis and Forecast

            12.11.1. Introduction

                12.11.1.1. Key Findings

            12.11.2. Market Value Forecast, by Product, 2020-2034

                12.11.2.1. Instruments

                12.11.2.2. Reagents and Consumables

            12.11.3. Market Value & Volume Forecast, by Test Type, 2020-2034

                12.11.3.1. Escherichia coli infection

                12.11.3.2. Staphylococcus aureus infection

                12.11.3.3. Enterococcus species infection

                12.11.3.4. Pseudomonas aeruginosa infection

                12.11.3.5. Clostridioides difficile infection

                12.11.3.6. Enterobacter Species

                12.11.3.7. Others

            12.11.4. Market Value Forecast, by Target Area, 2020-2034

                12.11.4.1. Bloodstream

                12.11.4.2. Urinary Tract

                12.11.4.3. Surgical Site

                12.11.4.4. Gastrointestinal

                12.11.4.5. Respiratory

                12.11.4.6. Others

            12.11.5. Market Value Forecast, by Sample Type, 2020-2034

                12.11.5.1. Blood

                12.11.5.2. Urine

                12.11.5.3. Stool

                12.11.5.4. Tissue

                12.11.5.5. Others

            12.11.6. Market Value Forecast, by End-user, 2020-2034

                12.11.6.1. Hospitals & Clinics

                12.11.6.2. Nursing Homes

                12.11.6.3. Ambulatory Surgical Centers

                12.11.6.4. Others

            12.11.7. Market Attractiveness Analysis

                12.11.7.1. By Product

                12.11.7.2. By Test Type

                12.11.7.3. By Target Area

                12.11.7.4. By Sample Type

                12.11.7.5. By End-user

        12.12. Italy Culture Test for Healthcare-associated Infections Market Analysis and Forecast

            12.12.1. Introduction

                12.12.1.1. Key Findings

            12.12.2. Market Value Forecast, by Product, 2020-2034

                12.12.2.1. Instruments

                12.12.2.2. Reagents and Consumables

            12.12.3. Market Value & Volume Forecast, by Test Type, 2020-2034

                12.12.3.1. Escherichia coli infection

                12.12.3.2. Staphylococcus aureus infection

                12.12.3.3. Enterococcus species infection

                12.12.3.4. Pseudomonas aeruginosa infection

                12.12.3.5. Clostridioides difficile infection

                12.12.3.6. Enterobacter Species

                12.12.3.7. Others

            12.12.4. Market Value Forecast, by Target Area, 2020-2034

                12.12.4.1. Bloodstream

                12.12.4.2. Urinary Tract

                12.12.4.3. Surgical Site

                12.12.4.4. Gastrointestinal

                12.12.4.5. Respiratory

                12.12.4.6. Others

            12.12.5. Market Value Forecast, by Sample Type, 2020-2034

                12.12.5.1. Blood

                12.12.5.2. Urine

                12.12.5.3. Stool

                12.12.5.4. Tissue

                12.12.5.5. Others

            12.12.6. Market Value Forecast, by End-user, 2020-2034

                12.12.6.1. Hospitals & Clinics

                12.12.6.2. Nursing Homes

                12.12.6.3. Ambulatory Surgical Centers

                12.12.6.4. Others

            12.12.7. Market Attractiveness Analysis

                12.12.7.1. By Product

                12.12.7.2. By Test Type

                12.12.7.3. By Target Area

                12.12.7.4. By Sample Type

                12.12.7.5. By End-user

        12.13. Spain Culture Test for Healthcare-associated Infections Market Analysis and Forecast

            12.13.1. Introduction

                12.13.1.1. Key Findings

            12.13.2. Market Value Forecast, by Product, 2020-2034

                12.13.2.1. Instruments

                12.13.2.2. Reagents and Consumables

            12.13.3. Market Value & Volume Forecast, by Test Type, 2020-2034

                12.13.3.1. Escherichia coli infection

                12.13.3.2. Staphylococcus aureus infection

                12.13.3.3. Enterococcus species infection

                12.13.3.4. Pseudomonas aeruginosa infection

                12.13.3.5. Clostridioides difficile infection

                12.13.3.6. Enterobacter Species

                12.13.3.7. Others

            12.13.4. Market Value Forecast, by Target Area, 2020-2034

                12.13.4.1. Bloodstream

                12.13.4.2. Urinary Tract

                12.13.4.3. Surgical Site

                12.13.4.4. Gastrointestinal

                12.13.4.5. Respiratory

                12.13.4.6. Others

            12.13.5. Market Value Forecast, by Sample Type, 2020-2034

                12.13.5.1. Blood

                12.13.5.2. Urine

                12.13.5.3. Stool

                12.13.5.4. Tissue

                12.13.5.5. Others

            12.13.6. Market Value Forecast, by End-user, 2020-2034

                12.13.6.1. Hospitals & Clinics

                12.13.6.2. Nursing Homes

                12.13.6.3. Ambulatory Surgical Centers

                12.13.6.4. Others

            12.13.7. Market Attractiveness Analysis

                12.13.7.1. By Product

                12.13.7.2. By Test Type

                12.13.7.3. By Target Area

                12.13.7.4. By Sample Type

                12.13.7.5. By End-user

        12.14. Switzerland Culture Test for Healthcare-associated Infections Market Analysis and Forecast

            12.14.1. Introduction

                12.14.1.1. Key Findings

            12.14.2. Market Value Forecast, by Product, 2020-2034

                12.14.2.1. Instruments

                12.14.2.2. Reagents and Consumables

            12.14.3. Market Value & Volume Forecast, by Test Type, 2020-2034

                12.14.3.1. Escherichia coli infection

                12.14.3.2. Staphylococcus aureus infection

                12.14.3.3. Enterococcus species infection

                12.14.3.4. Pseudomonas aeruginosa infection

                12.14.3.5. Clostridioides difficile infection

                12.14.3.6. Enterobacter Species

                12.14.3.7. Others

            12.14.4. Market Value Forecast, by Target Area, 2020-2034

                12.14.4.1. Bloodstream

                12.14.4.2. Urinary Tract

                12.14.4.3. Surgical Site

                12.14.4.4. Gastrointestinal

                12.14.4.5. Respiratory

                12.14.4.6. Others

            12.14.5. Market Value Forecast, by Sample Type, 2020-2034

                12.14.5.1. Blood

                12.14.5.2. Urine

                12.14.5.3. Stool

                12.14.5.4. Tissue

                12.14.5.5. Others

            12.14.6. Market Value Forecast, by End-user, 2020-2034

                12.14.6.1. Hospitals & Clinics

                12.14.6.2. Nursing Homes

                12.14.6.3. Ambulatory Surgical Centers

                12.14.6.4. Others

            12.14.7. Market Attractiveness Analysis

                12.14.7.1. By Product

                12.14.7.2. By Test Type

                12.14.7.3. By Target Area

                12.14.7.4. By Sample Type

                12.14.7.5. By End-user

        12.15. Netherlands Culture Test for Healthcare-associated Infections Market Analysis and Forecast

            12.15.1. Introduction

                12.15.1.1. Key Findings

            12.15.2. Market Value Forecast, by Product, 2020-2034

                12.15.2.1. Instruments

                12.15.2.2. Reagents and Consumables

            12.15.3. Market Value & Volume Forecast, by Test Type, 2020-2034

                12.15.3.1. Escherichia coli infection

                12.15.3.2. Staphylococcus aureus infection

                12.15.3.3. Enterococcus species infection

                12.15.3.4. Pseudomonas aeruginosa infection

                12.15.3.5. Clostridioides difficile infection

                12.15.3.6. Enterobacter Species

                12.15.3.7. Others

            12.15.4. Market Value Forecast, by Target Area, 2020-2034

                12.15.4.1. Bloodstream

                12.15.4.2. Urinary Tract

                12.15.4.3. Surgical Site

                12.15.4.4. Gastrointestinal

                12.15.4.5. Respiratory

                12.15.4.6. Others

            12.15.5. Market Value Forecast, by Sample Type, 2020-2034

                12.15.5.1. Blood

                12.15.5.2. Urine

                12.15.5.3. Stool

                12.15.5.4. Tissue

                12.15.5.5. Others

            12.15.6. Market Value Forecast, by End-user, 2020-2034

                12.15.6.1. Hospitals & Clinics

                12.15.6.2. Nursing Homes

                12.15.6.3. Ambulatory Surgical Centers

                12.15.6.4. Others

            12.15.7. Market Attractiveness Analysis

                12.15.7.1. By Product

                12.15.7.2. By Test Type

                12.15.7.3. By Target Area

                12.15.7.4. By Sample Type

                12.15.7.5. By End-user

        12.16. Rest of Europe Culture Test for Healthcare-associated Infections Market Analysis and Forecast

            12.16.1. Introduction

                12.16.1.1. Key Findings

            12.16.2. Market Value Forecast, by Product, 2020-2034

                12.16.2.1. Instruments

                12.16.2.2. Reagents and Consumables

            12.16.3. Market Value & Volume Forecast, by Test Type, 2020-2034

                12.16.3.1. Escherichia coli infection

                12.16.3.2. Staphylococcus aureus infection

                12.16.3.3. Enterococcus species infection

                12.16.3.4. Pseudomonas aeruginosa infection

                12.16.3.5. Clostridioides difficile infection

                12.16.3.6. Enterobacter Species

                12.16.3.7. Others

            12.16.4. Market Value Forecast, by Target Area, 2020-2034

                12.16.4.1. Bloodstream

                12.16.4.2. Urinary Tract

                12.16.4.3. Surgical Site

                12.16.4.4. Gastrointestinal

                12.16.4.5. Respiratory

                12.16.4.6. Others

            12.16.5. Market Value Forecast, by Sample Type, 2020-2034

                12.16.5.1. Blood

                12.16.5.2. Urine

                12.16.5.3. Stool

                12.16.5.4. Tissue

                12.16.5.5. Others

            12.16.6. Market Value Forecast, by End-user, 2020-2034

                12.16.6.1. Hospitals & Clinics

                12.16.6.2. Nursing Homes

                12.16.6.3. Ambulatory Surgical Centers

                12.16.6.4. Others

            12.16.7. Market Attractiveness Analysis

                12.16.7.1. By Product

                12.16.7.2. By Test Type

                12.16.7.3. By Target Area

                12.16.7.4. By Sample Type

                12.16.7.5. By End-user

    13. MEA Culture Test for Healthcare-associated Infections Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product, 2020-2034

            13.2.1. Instruments

            13.2.2. Reagents and Consumables

        13.3. Market Value & Volume Forecast, by Test Type, 2020-2034

            13.3.1. Escherichia coli infection

            13.3.2. Staphylococcus aureus infection

            13.3.3. Enterococcus species infection

            13.3.4. Pseudomonas aeruginosa infection

            13.3.5. Clostridioides difficile infection

            13.3.6. Enterobacter Species

            13.3.7. Others

        13.4. Market Value Forecast, by Target Area, 2020-2034

            13.4.1. Bloodstream

            13.4.2. Urinary Tract

            13.4.3. Surgical Site

            13.4.4. Gastrointestinal

            13.4.5. Respiratory

            13.4.6. Others

        13.5. Market Value Forecast, by Sample Type, 2020-2034

            13.5.1. Blood

            13.5.2. Urine

            13.5.3. Stool

            13.5.4. Tissue

            13.5.5. Others

        13.6. Market Value Forecast, by End-user, 2020-2034

            13.6.1. Hospitals & Clinics

            13.6.2. Nursing Homes

            13.6.3. Ambulatory Surgical Centers

            13.6.4. Others

        13.7. Market Value Forecast, by Country/Sub-region, 2020-2034

            13.7.1. Saudi Arabia

            13.7.2. UAE

            13.7.3. South Africa

            13.7.4. Turkey

            13.7.5. Egypt

            13.7.6. Israel

            13.7.7. Rest of MEA

        13.8. Market Attractiveness Analysis

            13.8.1. By Product

            13.8.2. By Test Type

            13.8.3. By Target Area

            13.8.4. By Sample Type

            13.8.5. By End-user

            13.8.6. By Country/Sub-region

        13.9. Saudi Arabia Culture Test for Healthcare-associated Infections Market Analysis and Forecast

            13.9.1. Introduction

                13.9.1.1. Key Findings

            13.9.2. Market Value Forecast, by Product, 2020-2034

                13.9.2.1. Instruments

                13.9.2.2. Reagents and Consumables

            13.9.3. Market Value & Volume Forecast, by Test Type, 2020-2034

                13.9.3.1. Escherichia coli infection

                13.9.3.2. Staphylococcus aureus infection

                13.9.3.3. Enterococcus species infection

                13.9.3.4. Pseudomonas aeruginosa infection

                13.9.3.5. Clostridioides difficile infection

                13.9.3.6. Enterobacter Species

                13.9.3.7. Others

            13.9.4. Market Value Forecast, by Target Area, 2020-2034

                13.9.4.1. Bloodstream

                13.9.4.2. Urinary Tract

                13.9.4.3. Surgical Site

                13.9.4.4. Gastrointestinal

                13.9.4.5. Respiratory

                13.9.4.6. Others

            13.9.5. Market Value Forecast, by Sample Type, 2020-2034

                13.9.5.1. Blood

                13.9.5.2. Urine

                13.9.5.3. Stool

                13.9.5.4. Tissue

                13.9.5.5. Others

            13.9.6. Market Value Forecast, by End-user, 2020-2034

                13.9.6.1. Hospitals & Clinics

                13.9.6.2. Nursing Homes

                13.9.6.3. Ambulatory Surgical Centers

                13.9.6.4. Others

            13.9.7. Market Attractiveness Analysis

                13.9.7.1. By Product

                13.9.7.2. By Test Type

                13.9.7.3. By Target Area

                13.9.7.4. By Sample Type

                13.9.7.5. By End-user

        13.10. UAE Culture Test for Healthcare-associated Infections Market Analysis and Forecast

            13.10.1. Introduction

                13.10.1.1. Key Findings

            13.10.2. Market Value Forecast, by Product, 2020-2034

                13.10.2.1. Instruments

                13.10.2.2. Reagents and Consumables

            13.10.3. Market Value & Volume Forecast, by Test Type, 2020-2034

                13.10.3.1. Escherichia coli infection

                13.10.3.2. Staphylococcus aureus infection

                13.10.3.3. Enterococcus species infection

                13.10.3.4. Pseudomonas aeruginosa infection

                13.10.3.5. Clostridioides difficile infection

                13.10.3.6. Enterobacter Species

                13.10.3.7. Others

            13.10.4. Market Value Forecast, by Target Area, 2020-2034

                13.10.4.1. Bloodstream

                13.10.4.2. Urinary Tract

                13.10.4.3. Surgical Site

                13.10.4.4. Gastrointestinal

                13.10.4.5. Respiratory

                13.10.4.6. Others

            13.10.5. Market Value Forecast, by Sample Type, 2020-2034

                13.10.5.1. Blood

                13.10.5.2. Urine

                13.10.5.3. Stool

                13.10.5.4. Tissue

                13.10.5.5. Others

            13.10.6. Market Value Forecast, by End-user, 2020-2034

                13.10.6.1. Hospitals & Clinics

                13.10.6.2. Nursing Homes

                13.10.6.3. Ambulatory Surgical Centers

                13.10.6.4. Others

            13.10.7. Market Attractiveness Analysis

                13.10.7.1. By Product

                13.10.7.2. By Test Type

                13.10.7.3. By Target Area

                13.10.7.4. By Sample Type

                13.10.7.5. By End-user

        13.11. South Africa Culture Test for Healthcare-associated Infections Market Analysis and Forecast

            13.11.1. Introduction

                13.11.1.1. Key Findings

            13.11.2. Market Value Forecast, by Product, 2020-2034

                13.11.2.1. Instruments

                13.11.2.2. Reagents and Consumables

            13.11.3. Market Value & Volume Forecast, by Test Type, 2020-2034

                13.11.3.1. Escherichia coli infection

                13.11.3.2. Staphylococcus aureus infection

                13.11.3.3. Enterococcus species infection

                13.11.3.4. Pseudomonas aeruginosa infection

                13.11.3.5. Clostridioides difficile infection

                13.11.3.6. Enterobacter Species

                13.11.3.7. Others

            13.11.4. Market Value Forecast, by Target Area, 2020-2034

                13.11.4.1. Bloodstream

                13.11.4.2. Urinary Tract

                13.11.4.3. Surgical Site

                13.11.4.4. Gastrointestinal

                13.11.4.5. Respiratory

                13.11.4.6. Others

            13.11.5. Market Value Forecast, by Sample Type, 2020-2034

                13.11.5.1. Blood

                13.11.5.2. Urine

                13.11.5.3. Stool

                13.11.5.4. Tissue

                13.11.5.5. Others

            13.11.6. Market Value Forecast, by End-user, 2020-2034

                13.11.6.1. Hospitals & Clinics

                13.11.6.2. Nursing Homes

                13.11.6.3. Ambulatory Surgical Centers

                13.11.6.4. Others

            13.11.7. Market Attractiveness Analysis

                13.11.7.1. By Product

                13.11.7.2. By Test Type

                13.11.7.3. By Target Area

                13.11.7.4. By Sample Type

                13.11.7.5. By End-user

        13.12. Turkey Culture Test for Healthcare-associated Infections Market Analysis and Forecast

            13.12.1. Introduction

                13.12.1.1. Key Findings

            13.12.2. Market Value Forecast, by Product, 2020-2034

                13.12.2.1. Instruments

                13.12.2.2. Reagents and Consumables

            13.12.3. Market Value & Volume Forecast, by Test Type, 2020-2034

                13.12.3.1. Escherichia coli infection

                13.12.3.2. Staphylococcus aureus infection

                13.12.3.3. Enterococcus species infection

                13.12.3.4. Pseudomonas aeruginosa infection

                13.12.3.5. Clostridioides difficile infection

                13.12.3.6. Enterobacter Species

                13.12.3.7. Others

            13.12.4. Market Value Forecast, by Target Area, 2020-2034

                13.12.4.1. Bloodstream

                13.12.4.2. Urinary Tract

                13.12.4.3. Surgical Site

                13.12.4.4. Gastrointestinal

                13.12.4.5. Respiratory

                13.12.4.6. Others

            13.12.5. Market Value Forecast, by Sample Type, 2020-2034

                13.12.5.1. Blood

                13.12.5.2. Urine

                13.12.5.3. Stool

                13.12.5.4. Tissue

                13.12.5.5. Others

            13.12.6. Market Value Forecast, by End-user, 2020-2034

                13.12.6.1. Hospitals & Clinics

                13.12.6.2. Nursing Homes

                13.12.6.3. Ambulatory Surgical Centers

                13.12.6.4. Others

            13.12.7. Market Attractiveness Analysis

                13.12.7.1. By Product

                13.12.7.2. By Test Type

                13.12.7.3. By Target Area

                13.12.7.4. By Sample Type

                13.12.7.5. By End-user

        13.13. Egypt Culture Test for Healthcare-associated Infections Market Analysis and Forecast

            13.13.1. Introduction

                13.13.1.1. Key Findings

            13.13.2. Market Value Forecast, by Product, 2020-2034

                13.13.2.1. Instruments

                13.13.2.2. Reagents and Consumables

            13.13.3. Market Value & Volume Forecast, by Test Type, 2020-2034

                13.13.3.1. Escherichia coli infection

                13.13.3.2. Staphylococcus aureus infection

                13.13.3.3. Enterococcus species infection

                13.13.3.4. Pseudomonas aeruginosa infection

                13.13.3.5. Clostridioides difficile infection

                13.13.3.6. Enterobacter Species

                13.13.3.7. Others

            13.13.4. Market Value Forecast, by Target Area, 2020-2034

                13.13.4.1. Bloodstream

                13.13.4.2. Urinary Tract

                13.13.4.3. Surgical Site

                13.13.4.4. Gastrointestinal

                13.13.4.5. Respiratory

                13.13.4.6. Others

            13.13.5. Market Value Forecast, by Sample Type, 2020-2034

                13.13.5.1. Blood

                13.13.5.2. Urine

                13.13.5.3. Stool

                13.13.5.4. Tissue

                13.13.5.5. Others

            13.13.6. Market Value Forecast, by End-user, 2020-2034

                13.13.6.1. Hospitals & Clinics

                13.13.6.2. Nursing Homes

                13.13.6.3. Ambulatory Surgical Centers

                13.13.6.4. Others

            13.13.7. Market Attractiveness Analysis

                13.13.7.1. By Product

                13.13.7.2. By Test Type

                13.13.7.3. By Target Area

                13.13.7.4. By Sample Type

                13.13.7.5. By End-user

        13.14. Israel Culture Test for Healthcare-associated Infections Market Analysis and Forecast

            13.14.1. Introduction

                13.14.1.1. Key Findings

            13.14.2. Market Value Forecast, by Product, 2020-2034

                13.14.2.1. Instruments

                13.14.2.2. Reagents and Consumables

            13.14.3. Market Value & Volume Forecast, by Test Type, 2020-2034

                13.14.3.1. Escherichia coli infection

                13.14.3.2. Staphylococcus aureus infection

                13.14.3.3. Enterococcus species infection

                13.14.3.4. Pseudomonas aeruginosa infection

                13.14.3.5. Clostridioides difficile infection

                13.14.3.6. Enterobacter Species

                13.14.3.7. Others

            13.14.4. Market Value Forecast, by Target Area, 2020-2034

                13.14.4.1. Bloodstream

                13.14.4.2. Urinary Tract

                13.14.4.3. Surgical Site

                13.14.4.4. Gastrointestinal

                13.14.4.5. Respiratory

                13.14.4.6. Others

            13.14.5. Market Value Forecast, by Sample Type, 2020-2034

                13.14.5.1. Blood

                13.14.5.2. Urine

                13.14.5.3. Stool

                13.14.5.4. Tissue

                13.14.5.5. Others

            13.14.6. Market Value Forecast, by End-user, 2020-2034

                13.14.6.1. Hospitals & Clinics

                13.14.6.2. Nursing Homes

                13.14.6.3. Ambulatory Surgical Centers

                13.14.6.4. Others

            13.14.7. Market Attractiveness Analysis

                13.14.7.1. By Product

                13.14.7.2. By Test Type

                13.14.7.3. By Target Area

                13.14.7.4. By Sample Type

                13.14.7.5. By End-user

        13.15. Rest of MEA Culture Test for Healthcare-associated Infections Market Analysis and Forecast

            13.15.1. Introduction

                13.15.1.1. Key Findings

            13.15.2. Market Value Forecast, by Product, 2020-2034

                13.15.2.1. Instruments

                13.15.2.2. Reagents and Consumables

            13.15.3. Market Value & Volume Forecast, by Test Type, 2020-2034

                13.15.3.1. Escherichia coli infection

                13.15.3.2. Staphylococcus aureus infection

                13.15.3.3. Enterococcus species infection

                13.15.3.4. Pseudomonas aeruginosa infection

                13.15.3.5. Clostridioides difficile infection

                13.15.3.6. Enterobacter Species

                13.15.3.7. Others

            13.15.4. Market Value Forecast, by Target Area, 2020-2034

                13.15.4.1. Bloodstream

                13.15.4.2. Urinary Tract

                13.15.4.3. Surgical Site

                13.15.4.4. Gastrointestinal

                13.15.4.5. Respiratory

                13.15.4.6. Others

            13.15.5. Market Value Forecast, by Sample Type, 2020-2034

                13.15.5.1. Blood

                13.15.5.2. Urine

                13.15.5.3. Stool

                13.15.5.4. Tissue

                13.15.5.5. Others

            13.15.6. Market Value Forecast, by End-user, 2020-2034

                13.15.6.1. Hospitals & Clinics

                13.15.6.2. Nursing Homes

                13.15.6.3. Ambulatory Surgical Centers

                13.15.6.4. Others

            13.15.7. Market Attractiveness Analysis

                13.15.7.1. By Product

                13.15.7.2. By Test Type

                13.15.7.3. By Target Area

                13.15.7.4. By Sample Type

                13.15.7.5. By End-user

    14. Competition Landscape

        14.1. Market Player - Competition Matrix (By Tier and Size of Companies)

        14.2. Market Share Analysis, by Company (2023)

        14.3. Company Profiles

            14.3.1. Abbott Laboratories

                14.3.1.1. Company Overview

                14.3.1.2. Financial Overview

                14.3.1.3. Product Portfolio

                14.3.1.4. Business Strategies

                14.3.1.5. Recent Developments

            14.3.2. Merck KGA

                14.3.2.1. Company Overview

                14.3.2.2. Financial Overview

                14.3.2.3. Product Portfolio

                14.3.2.4. Business Strategies

                14.3.2.5. Recent Developments

            14.3.3. Becton Dickinson and Company

                14.3.3.1. Company Overview

                14.3.3.2. Financial Overview

                14.3.3.3. Product Portfolio

                14.3.3.4. Business Strategies

                14.3.3.5. Recent Developments

            14.3.4. Steris Plc

                14.3.4.1. Company Overview

                14.3.4.2. Financial Overview

                14.3.4.3. Product Portfolio

                14.3.4.4. Business Strategies

                14.3.4.5. Recent Developments

            14.3.5. Hologic, Inc.

                14.3.5.1. Company Overview

                14.3.5.2. Financial Overview

                14.3.5.3. Product Portfolio

                14.3.5.4. Business Strategies

                14.3.5.5. Recent Developments

            14.3.6. bioMerieux SA

                14.3.6.1. Company Overview

                14.3.6.2. Financial Overview

                14.3.6.3. Product Portfolio

                14.3.6.4. Business Strategies

                14.3.6.5. Recent Developments

            14.3.7. F. Hoffmann-La Roche AG

                14.3.7.1. Company Overview

                14.3.7.2. Financial Overview

                14.3.7.3. Product Portfolio

                14.3.7.4. Business Strategies

                14.3.7.5. Recent Developments

            14.3.8. Siemens Healthineers AG

                14.3.8.1. Company Overview

                14.3.8.2. Financial Overview

                14.3.8.3. Product Portfolio

                14.3.8.4. Business Strategies

                14.3.8.5. Recent Developments

            14.3.9. Thermo Fisher Scientific Inc.

                14.3.9.1. Company Overview

                14.3.9.2. Financial Overview

                14.3.9.3. Product Portfolio

                14.3.9.4. Business Strategies

                14.3.9.5. Recent Developments

            14.3.10. Hardy Diagnostics

                14.3.10.1. Company Overview

                14.3.10.2. Financial Overview

                14.3.10.3. Product Portfolio

                14.3.10.4. Business Strategies

                14.3.10.5. Recent Developments

            14.3.11. Bio-Rad Laboratories, Inc.

                14.3.11.1. Company Overview

                14.3.11.2. Financial Overview

                14.3.11.3. Product Portfolio

                14.3.11.4. Business Strategies

                14.3.11.5. Recent Developments

            14.3.12. Danaher Corporation

                14.3.12.1. Company Overview

                14.3.12.2. Financial Overview

                14.3.12.3. Product Portfolio

                14.3.12.4. Business Strategies

                14.3.12.5. Recent Developments

            14.3.13. SSI Diagnostica A/S

                14.3.13.1. Company Overview

                14.3.13.2. Financial Overview

                14.3.13.3. Product Portfolio

                14.3.13.4. Business Strategies

                14.3.13.5. Recent Developments

    List of Tables

    Table 01: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

    Table 02: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

    Table 03: Europe and MEA Culture Test for Healthcare-associated Infections Market Volume (Thousand Units) Forecast, by Test Type, 2020-2034

    Table 04: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

    Table 05: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

    Table 06: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 07: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Region, 2020-2034

    Table 08: Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Country / Sub-region, 2020-2034

    Table 09: Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

    Table 10: Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

    Table 11: Europe Culture Test for Healthcare-associated Infections Market Volume (Thousand Units) Forecast, by Test Type, 2020-2034

    Table 12: Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

    Table 13: Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

    Table 14: Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 15: Germany Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

    Table 16: Germany Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

    Table 17: Germany Culture Test for Healthcare-associated Infections Market Volume (Thousand Units) Forecast, by Test Type, 2020-2034

    Table 18: Germany Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

    Table 19: Germany Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

    Table 20: Germany Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 21: U.K. Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

    Table 22: U.K. Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

    Table 23: U.K. Culture Test for Healthcare-associated Infections Market Volume (Thousand Units) Forecast, by Test Type, 2020-2034

    Table 24: U.K. Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

    Table 25: U.K. Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

    Table 26: U.K. Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 27: France Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

    Table 28: France Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

    Table 29: France Culture Test for Healthcare-associated Infections Market Volume (Thousand Units) Forecast, by Test Type, 2020-2034

    Table 30: France Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

    Table 31: France Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

    Table 32: France Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 33: Italy Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

    Table 34: Italy Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

    Table 35: Italy Culture Test for Healthcare-associated Infections Market Volume (Thousand Units) Forecast, by Test Type, 2020-2034

    Table 36: Italy Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

    Table 37: Italy Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

    Table 38: Italy Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 39: Spain Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

    Table 40: Spain Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

    Table 41: Spain Culture Test for Healthcare-associated Infections Market Volume (Thousand Units) Forecast, by Test Type, 2020-2034

    Table 42: Spain Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

    Table 43: Spain Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

    Table 44: Spain Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 45: Switzerland Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

    Table 46: Switzerland Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

    Table 47: Switzerland Culture Test for Healthcare-associated Infections Market Volume Forecast, by Test Type, 2020-2034

    Table 48: Switzerland Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

    Table 49: Switzerland Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

    Table 50: Switzerland Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 51: Netherlands Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

    Table 52: Netherlands Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

    Table 53: Netherlands Culture Test for Healthcare-associated Infections Market Volume Forecast, by Test Type, 2020-2034

    Table 54: Netherlands Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

    Table 55: Netherlands Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

    Table 56: Netherlands Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 57: Rest of Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

    Table 58: Rest of Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

    Table 59: Rest of Europe Culture Test for Healthcare-associated Infections Market Volume Forecast, by Test Type, 2020-2034

    Table 60: Rest of Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

    Table 61: Rest of Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

    Table 62: Rest of Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 63: Middle East and Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

    Table 64: Middle East and Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

    Table 65: Middle East and Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

    Table 66: Middle East and Africa Culture Test for Healthcare-associated Infections Market Volume (Thousand Units) Forecast, by Test Type, 2020-2034

    Table 67: Middle East and Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

    Table 68: Middle East and Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

    Table 69: Middle East and Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 70: Saudi Arabia Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

    Table 71: Saudi Arabia Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

    Table 72: Saudi Arabia Culture Test for Healthcare-associated Infections Market Volume (Thousand Units) Forecast, by Test Type, 2020-2034

    Table 73: Saudi Arabia Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

    Table 74: Saudi Arabia Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

    Table 75: Saudi Arabia Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 76: UAE Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

    Table 77: UAE Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

    Table 78: UAE Culture Test for Healthcare-associated Infections Market Volume (Thousand Units) Forecast, by Test Type, 2020-2034

    Table 79: UAE Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

    Table 80: UAE Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

    Table 81: UAE Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 82: South Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

    Table 83: South Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

    Table 84: South Africa Culture Test for Healthcare-associated Infections Market Volume (Thousand Units) Forecast, by Test Type, 2020-2034

    Table 85: South Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

    Table 86: South Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

    Table 87: South Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 88: Turkey Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

    Table 89: Turkey Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

    Table 90: Turkey Culture Test for Healthcare-associated Infections Market Volume (Thousand Units) Forecast, by Test Type, 2020-2034

    Table 91: Turkey Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

    Table 92: Turkey Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

    Table 93: Turkey Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 94: Egypt Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

    Table 95: Egypt Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

    Table 96: Egypt Culture Test for Healthcare-associated Infections Market Volume (Thousand Units) Forecast, by Test Type, 2020-2034

    Table 97: Egypt Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

    Table 98: Egypt Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

    Table 99: Egypt Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 100: Israel Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

    Table 101: Israel Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

    Table 102: Israel Culture Test for Healthcare-associated Infections Market Volume (Thousand Units) Forecast, by Test Type, 2020-2034

    Table 103: Israel Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

    Table 104: Israel Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

    Table 105: Israel Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 106: Rest of MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Product, 2020-2034

    Table 107: Rest of MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

    Table 108: Rest of MEA Culture Test for Healthcare-associated Infections Market Volume Forecast, by Test Type, 2020-2034

    Table 109: Rest of MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Target Area, 2020-2034

    Table 110: Rest of MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by Sample Type, 2020-2034

    Table 111: Rest of MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    List of Figures

    Figure 01: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Forecast, 2020-2034

    Figure 02: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share, by Product, 2023

    Figure 03: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share, by Test Type, 2023

    Figure 04: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share, by Target Area, 2023

    Figure 05: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share, by Sample Type, 2023

    Figure 06: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share, by End-user, 2023

    Figure 07: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

    Figure 08: Europe and MEA Culture Test for Healthcare-associated Infections Market Share Analysis, by Product, 2023

    Figure 09: Europe and MEA Culture Test for Healthcare-associated Infections Market Share Analysis, by Product, 2034

    Figure 10: Europe and MEA Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

    Figure 11: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Instruments, 2020-2034

    Figure 12: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Instruments, 2023 and 2034

    Figure 13: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Reagents and Consumables, 2020-2034

    Figure 14: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Reagents and Consumables, 2023 and 2034

    Figure 15: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Test Type, 2023 and 2034

    Figure 16: Europe and MEA Culture Test for Healthcare-associated Infections Market Share Analysis, by Test Type, 2023

    Figure 17: Europe and MEA Culture Test for Healthcare-associated Infections Market Share Analysis, by Test Type, 2034

    Figure 18: Europe and MEA Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Test Type, 2024-2034

    Figure 19: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Escherichia coli infection, 2020-2034

    Figure 20: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Escherichia coli infection, 2023 and 2034

    Figure 21: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Staphylococcus aureus infection, 2020-2034

    Figure 22: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Staphylococcus aureus infection, 2023 and 2034

    Figure 23: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Enterococcus species infection, 2020-2034

    Figure 24: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Enterococcus species infection, 2023 and 2034

    Figure 25: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Pseudomonas aeruginosa infection, 2020-2034

    Figure 26: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Pseudomonas aeruginosa infection, 2023 and 2034

    Figure 27: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Clostridioides diffcile infection, 2020-2034

    Figure 28: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Clostridioides diffcile infection, 2023 and 2034

    Figure 29: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Enterobacter Species, 2020-2034

    Figure 30: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Enterobacter Species, 2023 and 2034

    Figure 31: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Others, 2020-2034

    Figure 32: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Others, 2023 and 2034

    Figure 33: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

    Figure 34: Europe and MEA Culture Test for Healthcare-associated Infections Market Share Analysis, by Target Area, 2023

    Figure 35: Europe and MEA Culture Test for Healthcare-associated Infections Market Share Analysis, by Test Type, 2034

    Figure 36: Europe and MEA Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

    Figure 37: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Bloodstream, 2020-2034

    Figure 38: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Bloodstream, 2023 and 2034

    Figure 39: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Urinary Tract, 2020-2034

    Figure 40: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Urinary Tract, 2023 and 2034

    Figure 41: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Surgical Site, 2020-2034

    Figure 42: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Surgical Site, 2023 and 2034

    Figure 43: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Gastrointestinal, 2020-2034

    Figure 44: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Gastrointestinal, 2023 and 2034

    Figure 45: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Respiratory, 2020-2034

    Figure 46: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Respiratory, 2023 and 2034

    Figure 47: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Others, 2020-2034

    Figure 48: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Others, 2023 and 2034

    Figure 49: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

    Figure 50: Europe and MEA Culture Test for Healthcare-associated Infections Market Share Analysis, by Sample Type, 2023

    Figure 51: Europe and MEA Culture Test for Healthcare-associated Infections Market Share Analysis, by Test Type, 2034

    Figure 52: Europe and MEA Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

    Figure 53: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Blood, 2020-2034

    Figure 54: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Blood, 2023 and 2034

    Figure 55: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Urine, 2020-2034

    Figure 56: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Urine, 2023 and 2034

    Figure 57: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Stool, 2020-2034

    Figure 58: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Stool, 2023 and 2034

    Figure 59: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Tissue, 2020-2034

    Figure 60: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Tissue, 2023 and 2034

    Figure 61: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Others, 2020-2034

    Figure 62: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Others, 2023 and 2034

    Figure 63: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 64: Europe and MEA Culture Test for Healthcare-associated Infections Market Share Analysis, by End-user, 2023

    Figure 65: Europe and MEA Culture Test for Healthcare-associated Infections Market Share Analysis, by End-user, 2034

    Figure 66: Europe and MEA Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

    Figure 67: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Hospitals & Clinics, 2020-2034

    Figure 68: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Hospitals & Clinics, 2023 and 2034

    Figure 69: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Nursing Homes, 2020-2034

    Figure 70: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Nursing Homes, 2023 and 2034

    Figure 71: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Ambulatory Surgical Centers, 2020-2034

    Figure 72: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Ambulatory Surgical Centers, 2023 and 2034

    Figure 73: Europe and MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn), by Others, 2020-2034

    Figure 74: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Others, 2023 and 2034

    Figure 75: Europe and MEA Culture Test for Healthcare-associated Infections Market Value Share Analysis, by Region, 2023 and 2034

    Figure 76: Europe and MEA Culture Test for Healthcare-associated Infections Market Share Analysis, by Region, 2023

    Figure 77: Europe and MEA Culture Test for Healthcare-associated Infections Market Share Analysis, by Region, 2034

    Figure 78: Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Country / Sub-region, 2023 and 2034

    Figure 79: Europe Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Country / Sub-region, 2024-2034

    Figure 80: Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

    Figure 81: Europe Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

    Figure 82: Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

    Figure 83: Europe Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

    Figure 84: Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

    Figure 85: Europe Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

    Figure 86: Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

    Figure 87: Europe Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

    Figure 88: Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 89: Europe Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

    Figure 90: Germany Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

    Figure 91: Germany Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

    Figure 92: Germany Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

    Figure 93: Germany Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

    Figure 94: Germany Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

    Figure 95: Germany Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

    Figure 96: Germany Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

    Figure 97: Germany Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

    Figure 98: Germany Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 99: Germany Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

    Figure 100: U.K. Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

    Figure 101: U.K. Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

    Figure 102: U.K. Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

    Figure 103: U.K. Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

    Figure 104: U.K. Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

    Figure 105: U.K. Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

    Figure 106: U.K. Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

    Figure 107: U.K. Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

    Figure 108: U.K. Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 109: U.K. Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

    Figure 110: France Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

    Figure 111: France Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

    Figure 112: France Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

    Figure 113: France Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

    Figure 114: France Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

    Figure 115: France Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

    Figure 116: France Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

    Figure 117: France Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

    Figure 118: France Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 119: France Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

    Figure 120: Italy Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

    Figure 121: Italy Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

    Figure 122: Italy Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

    Figure 123: Italy Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

    Figure 124: Italy Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

    Figure 125: Italy Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

    Figure 126: Italy Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

    Figure 127: Italy Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

    Figure 128: Italy Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 129: Italy Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

    Figure 130: Spain Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

    Figure 131: Spain Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

    Figure 132: Spain Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

    Figure 133: Spain Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

    Figure 134: Spain Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

    Figure 135: Spain Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

    Figure 136: Spain Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

    Figure 137: Spain Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

    Figure 138: Spain Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 139: Spain Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

    Figure 140: Switzerland Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

    Figure 141: Switzerland Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

    Figure 142: Switzerland Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

    Figure 143: Switzerland Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

    Figure 144: Switzerland Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

    Figure 145: Switzerland Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

    Figure 146: Switzerland Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

    Figure 147: Switzerland Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

    Figure 148: Switzerland Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 149: Switzerland Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

    Figure 150: Netherlands Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

    Figure 151: Netherlands Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

    Figure 152: Netherlands Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

    Figure 153: Netherlands Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

    Figure 154: Netherlands Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

    Figure 155: Netherlands Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

    Figure 156: Netherlands Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

    Figure 157: Netherlands Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

    Figure 158: Netherlands Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 159: Netherlands Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

    Figure 160: Rest of Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

    Figure 161: Rest of Europe Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

    Figure 162: Rest of Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

    Figure 163: Rest of Europe Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

    Figure 164: Rest of Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

    Figure 165: Rest of Europe Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

    Figure 166: Rest of Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

    Figure 167: Rest of Europe Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

    Figure 168: Rest of Europe Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 169: Rest of Europe Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

    Figure 170: Middle East and Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Country, 2023 and 2034

    Figure 171: Middle East and Africa Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Country, 2024-2034

    Figure 172: Middle East and Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

    Figure 173: Middle East and Africa Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

    Figure 174: Middle East and Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

    Figure 175: Middle East and Africa Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

    Figure 176: Middle East and Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

    Figure 177: Middle East and Africa Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

    Figure 178: Middle East and Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

    Figure 179: Middle East and Africa Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

    Figure 180: Middle East and Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 181: Middle East and Africa Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

    Figure 182: Saudi Arabia Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

    Figure 183: Saudi Arabia Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

    Figure 184: Saudi Arabia Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

    Figure 185: Saudi Arabia Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

    Figure 186: Saudi Arabia Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

    Figure 187: Saudi Arabia Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

    Figure 188: Saudi Arabia Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

    Figure 189: Saudi Arabia Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

    Figure 190: Saudi Arabia Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 191: Saudi Arabia Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

    Figure 192: UAE Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

    Figure 193: UAE Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

    Figure 194: UAE Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

    Figure 195: UAE Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

    Figure 196: UAE Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

    Figure 197: UAE Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

    Figure 198: UAE Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

    Figure 199: UAE Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

    Figure 200: UAE Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 201: UAE Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

    Figure 202: South Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

    Figure 203: South Africa Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

    Figure 204: South Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

    Figure 205: South Africa Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

    Figure 206: South Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

    Figure 207: South Africa Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

    Figure 208: South Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

    Figure 209: South Africa Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

    Figure 210: South Africa Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 211: South Africa Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

    Figure 212: Turkey Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

    Figure 213: Turkey Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

    Figure 214: Turkey Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

    Figure 215: Turkey Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

    Figure 216: Turkey Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

    Figure 217: Turkey Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

    Figure 218: Turkey Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

    Figure 219: Turkey Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

    Figure 220: Turkey Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 221: Turkey Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

    Figure 222: Egypt Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

    Figure 223: Egypt Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

    Figure 224: Egypt Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

    Figure 225: Egypt Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

    Figure 226: Egypt Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

    Figure 227: Egypt Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

    Figure 228: Egypt Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

    Figure 229: Egypt Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

    Figure 230: Egypt Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 231: Egypt Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

    Figure 232: Israel Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

    Figure 233: Israel Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

    Figure 234: Israel Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

    Figure 235: Israel Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

    Figure 236: Israel Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

    Figure 237: Israel Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

    Figure 238: Israel Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

    Figure 239: Israel Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

    Figure 240: Israel Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 241: Israel Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

    Figure 242: Rest of MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034

    Figure 243: Rest of MEA Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Product, 2024-2034

    Figure 244: Rest of MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

    Figure 245: Rest of MEA Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Application, 2024-2034

    Figure 246: Rest of MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Target Area, 2023 and 2034

    Figure 247: Rest of MEA Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Target Area, 2024-2034

    Figure 248: Rest of MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by Sample Type, 2023 and 2034

    Figure 249: Rest of MEA Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by Sample Type, 2024-2034

    Figure 250: Rest of MEA Culture Test for Healthcare-associated Infections Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 251: Rest of MEA Culture Test for Healthcare-associated Infections Market Attractiveness Analysis, by End-user, 2024-2034

Copyright © Transparency Market Research, Inc. All Rights reserved

Europe and MEA Culture Test for Healthcare-associated Infections Market

Schedule a Call